Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets (2016)
Historic Current Deferred Tax Assets for Enanta Pharmaceuticals (ENTA) over the last 3 years, with Q2 2016 value amounting to $1.1 million.
- Enanta Pharmaceuticals' Current Deferred Tax Assets fell 3471.83% to $1.1 million in Q2 2016 from the same period last year, while for Jun 2016 it was $1.1 million, marking a year-over-year decrease of 3471.83%. This contributed to the annual value of $1.4 million for FY2015, which is 8699.09% down from last year.
- Latest data reveals that Enanta Pharmaceuticals reported Current Deferred Tax Assets of $1.1 million as of Q2 2016, which was down 3471.83% from $1.6 million recorded in Q1 2016.
- In the past 5 years, Enanta Pharmaceuticals' Current Deferred Tax Assets registered a high of $11.2 million during Q2 2014, and its lowest value of $1.1 million during Q2 2016.
- In the last 3 years, Enanta Pharmaceuticals' Current Deferred Tax Assets had a median value of $1.6 million in 2015 and averaged $3.6 million.
- Over the last 5 years, Enanta Pharmaceuticals' Current Deferred Tax Assets had its largest YoY gain of 1728.49% in 2015, and its largest YoY loss of 8699.09% in 2015.
- Over the past 3 years, Enanta Pharmaceuticals' Current Deferred Tax Assets (Quarter) stood at $1.3 million in 2014, then grew by 17.28% to $1.6 million in 2015, then dropped by 27.45% to $1.1 million in 2016.
- Its Current Deferred Tax Assets stands at $1.1 million for Q2 2016, versus $1.6 million for Q1 2016 and $1.6 million for Q4 2015.